Linezolid, 98%, Thermo Scientific Chemicals
Linezolid, 98%, Thermo Scientific Chemicals
Thermo Scientific Chemicals

Linezolid, 98%, Thermo Scientific Chemicals

Linezolid, Zyvox, CAS # 165800-03-3 is a synthetic oxazolidinone antibiotic.
Have Questions?
Change viewbuttonViewtableView
Quantity:
1 g
250 mg
This chemical may require us to obtain additional information for our regulatory and chemical compliance records. If required, we will contact you for this information once your order is placed.
Catalog number 460590010
Price (USD)/ Each
357.65
Special Offer
Online exclusive
Ends: 31-Dec-2024
421.00 
Save 63.35 (15%)
-
Add to cart
Quantity:
1 g
Request bulk or custom format
Price (USD)/ Each
357.65
Special Offer
Online exclusive
Ends: 31-Dec-2024
421.00 
Save 63.35 (15%)
Add to cart
Linezolid, 98%, Thermo Scientific Chemicals
Catalog number460590010
Price (USD)/ Each
357.65
Special Offer
Online exclusive
Ends: 31-Dec-2024
421.00 
Save 63.35 (15%)
-
Add to cart
Chemical Identifiers
CAS165800-03-3
IUPAC NameN-{[(5S)-3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide
Molecular FormulaC16H20FN3O4
InChI KeyTYZROVQLWOKYKF-ZDUSSCGKSA-N
SMILESCC(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(N2CCOCC2)C(F)=C1
View more
SpecificationsSpecification SheetSpecification Sheet
Appearance (Form)Powder
HPLC>=97.5 %
Loss on drying=<0.5 %
Infrared spectrumConforms
Appearance (Color)White to off-white
This Thermo Scientific Chemicals brand product was originally part of the Acros Organics product portfolio. Some documentation and label information may refer to the legacy brand. The original Acros Organics product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

General Description

• Linezolid is an organoflourine compound and an acetamide

• Linezolid acts by inhibiting initiation complex formation by binding to the 50S ribosomal subunit

Applications

• Linezolid is effective against staphylococcal and enterococcal microbes

• It is most effective against gram-positive organisms, particularly methicillin, vancomycin and penicillin resistant ones

• Suitable for research on antibiotic resistance, cross-reactivity and drug mechanisms

RUO – Research Use Only

General References:

  1. Conradie, F.; Diacon, A.H.; Ngubane, N.; Howell, P.; Everitt, D.; Crook, A.M.; Mendel, C.M.; Egizi, E.; Moreira, J.; Timm, J.; McHugh, T.D.; Wills, G.H.; Bateson, A.; Hunt, R.; Van Niekerk, C.; Li, M.; Olugbosi, M.; Spigelman, M. Nix-TB Trial Team. Treatment of Highly Drug-Resistant Pulmonary Tuberculosis. N Engl J Med. 2020, 382(10), 893-902.
  2. Willekens, R.; Puig-Asensio, M.; Ruiz-Camps, I.; Larrosa, M.N.; González-López, J.J.; Rodríguez-Pardo, D.; Fernández-Hidalgo, N.; Pigrau, C.; Almirante, B. Early Oral Switch to Linezolid for Low-risk Patients With Staphylococcus aureus Bloodstream Infections: A Propensity-matched Cohort Study. Clin Infect Dis. 2019, 69(3), 381-387.